Sarepta sells Arrowhead shares as partnership, debt payments loom
Liquidating its stake in Arrowhead helps Sarepta cover a milestone payment and secure what one analyst described as “additional breathing room” ahead of a debt maturity in 2027.
Previous Post
The Discharge Severity Index: Early Research on ED Readmission Risk Assessment
Next Post
The Next Big Thing in AI? Building Your Own Tools
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago